IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Journal of Leukemia and Lymphoma

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

0.03

h-Index

2022-2023

 4

Rank

2022-2023

 27041

SJR

2022-2023

 0.101

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Journal of Leukemia and Lymphoma
Abbreviation J. Leuk. Lymphoma
Publication Type Journal
Subject Area, Categories, Scope Cancer Research (Q4); Hematology (Q4); Oncology (Q4)
h-index 4
Overall Rank/Ranking 27041
SCImago Journal Rank (SJR) 0.101
Impact Score 0.03
Publisher Chinese Medical Journals Publishing House Co.Ltd
Country China
ISSN 10099921
Best Quartile Q4
Coverage History 2008-2022




About Journal of Leukemia and Lymphoma


Journal of Leukemia and Lymphoma is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Hematology (Q4); Oncology (Q4). It is published by Chinese Medical Journals Publishing House Co.Ltd. The overall rank of Journal of Leukemia and Lymphoma is 27041. According to SCImago Journal Rank (SJR), this journal is ranked 0.101. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 4. The best quartile for this journal is Q4.

The ISSN of Journal of Leukemia and Lymphoma journal is 10099921. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Leukemia and Lymphoma is cited by a total of 10 articles during the last 3 years (Preceding 2022).


Journal of Leukemia and Lymphoma Impact IF 2022-2023


The Impact IF 2022 of Journal of Leukemia and Lymphoma is 0.03, which is computed in 2023 as per its definition. Journal of Leukemia and Lymphoma IF is increased by a factor of 0 and approximate percentage change is 0% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal of Leukemia and Lymphoma Impact IF 2023 Prediction


Impact IF 2022 of Journal of Leukemia and Lymphoma is 0.03. If the same upward trend persists, Impact IF may rise in 2023 as well.


Impact IF Trend


Year wise Impact IF of Journal of Leukemia and Lymphoma. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 0.03
2021 0.03
2020 0.12
2019 0.10
2018 0.36
2017 0.13
2016 0.16
2015 0.01
2014 0.01

Journal of Leukemia and Lymphoma h-index


  Table Setting

Journal of Leukemia and Lymphoma has an h-index of 4. It means 4 articles of this journal have more than 4 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal of Leukemia and Lymphoma ISSN


The ISSN of Journal of Leukemia and Lymphoma is 10099921. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal of Leukemia and Lymphoma Rank and SCImago Journal Rank (SJR)


The overall rank of Journal of Leukemia and Lymphoma is 27041. According to SCImago Journal Rank (SJR), this journal is ranked 0.101. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Journal of Leukemia and Lymphoma by Year


Year SJR
2023/2024 Coming Soon
2022 0.101
2021 0.105
2020 0.109
2019 0.184
2018 0.142
2017 0.113
2016 0.112
2015 0.102
2014 0.101

Ranking of Journal of Leukemia and Lymphoma by Year


Year Ranking
2023/2024 Coming Soon
2022 27041
2021 24966
2020 28816
2019 19495
2018 22171
2017 26573
2016 26673
2015 29059
2014 29485

Journal of Leukemia and Lymphoma Publisher


Table Setting

Journal of Leukemia and Lymphoma is published by Chinese Medical Journals Publishing House Co.Ltd. It's publishing house is located in China. Coverage history of this journal is as following: 2008-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal of Leukemia and Lymphoma is J. Leuk. Lymphoma. This abbreviation ('J. Leuk. Lymphoma') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal of Leukemia and Lymphoma


If your research field is/are related to Cancer Research (Q4); Hematology (Q4); Oncology (Q4), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Journal of Leukemia and Lymphoma?

Journal of Leukemia and Lymphoma latest impact IF is 0.03. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.36 (2018) and 0.01 (2015), respectively, in the last 9 years. Moreover, its average IS is 0.11 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Journal of Leukemia and Lymphoma?

The Journal of Leukemia and Lymphoma has an SJR (SCImago Journal Rank) of 0.101, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.184 in 2019 and the lowest being 0.101 in 2022. Furthermore, the average SJR of the Journal of Leukemia and Lymphoma over the previous 9-year period stands at 0.11.


What's the latest h-index of the Journal of Leukemia and Lymphoma?

The latest h-index of the Journal of Leukemia and Lymphoma is 4.


Who's the publisher of the Journal of Leukemia and Lymphoma?

The Journal of Leukemia and Lymphoma is published by the Chinese Medical Journals Publishing House Co.Ltd, with its country of publication being the China.


What's the current ranking of the Journal of Leukemia and Lymphoma?

The Journal of Leukemia and Lymphoma is currently ranked 27041 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 19495 in 2019 and its lowest position of 29485 in 2014.


What's the abbreviation or short name for the Journal of Leukemia and Lymphoma?

The standard ISO4 abbreviation for the Journal of Leukemia and Lymphoma is J. Leuk. Lymphoma.


Is the "Journal of Leukemia and Lymphoma" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Journal of Leukemia and Lymphoma is classified as a journal that the Chinese Medical Journals Publishing House Co.Ltd publishes.


What's the scope or major areas of the Journal of Leukemia and Lymphoma?

The Journal of Leukemia and Lymphoma encompasses the following areas:

  • Cancer Research
  • Hematology
  • Oncology

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Journal of Leukemia and Lymphoma?

The Journal of Leukemia and Lymphoma is assigned the following International Standard Serial Numbers (ISSN): 10099921.


What's the best quartile of the Journal of Leukemia and Lymphoma?

The best quartile for the Journal of Leukemia and Lymphoma is Q4 (2022).


What's the coverage history of the Journal of Leukemia and Lymphoma?

The Journal of Leukemia and Lymphoma coverage history can be summarized as follows: 2008-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Clinical Medicine and Research journal 16602 Marshfield Clinic 60 1.06
Discourse journal 6621 Routledge 59 2.11
International Journal of Parallel, Emergent and Distributed Systems journal 15843 Taylor and Francis Ltd. 23 1.28
Journal of Sociology journal 6009 SAGE Publications Ltd 58 3.21
Analytical Chemistry Insights journal 6696 Libertas Academica Ltd. 20 0.00
Indian Journal of Rheumatology journal 18638 Wolters Kluwer Medknow Publications 15 0.44
International Journal of Mechanical and Materials Engineering journal 10475 Springer Nature Switzerland AG 31 2.92
International Journal of Environment and Waste Management journal 18983 Inderscience Enterprises Ltd. 22 0.73
International Journal of Agriculture and Biology journal 17873 Friends Science Publishers 47 0.73
Physics and Chemistry of Glasses: European Journal of Glass Science and Technology Part B journal 18597 Society of Glass Technology 28 0.43

Check complete list




Year wise Impact Score (IS) of Journal of Leukemia and Lymphoma

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 0.03
2021 0.03
2020 0.12
2019 0.10
2018 0.36
2017 0.13
2016 0.16
2015 0.01
2014 0.01



Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Blood
Elsevier BV | United States

Lancet Haematology,The
Lancet Publishing Group | United Kingdom

Blood Cancer Journal
Nature Publishing Group | United States

Leukemia
Nature Publishing Group | United Kingdom

Journal of Thrombosis and Haemostasis
Wiley-Blackwell Publishing Ltd | United Kingdom

Blood advances
Elsevier BV | United States

American Journal of Hematology
Wiley-Liss Inc. | United States

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All